Acquired
Novo Nordisk (Ozempic)
Ben Gilbert
Yeah. It's interesting to think about the fact that these companies thought that biosimilars weren't just going to waltz in and, you know, eat their lunch and arbitrage all the profits away. Over time, the market for insulin became sufficiently large that they just had a target on their back. The prize became worth it.
0
💬
0
Comments
Log in to comment.
There are no comments yet.